2 Cases Remanded To State Court From GSK Avandia MDL

Law360, New York (April 06, 2012, 1:37 PM ET) -- A federal judge on Wednesday sent two cases back to state court from a multidistrict litigation against GlaxoSmithKline PLC for alleged Medicaid fraud related to its diabetes drug Avandia, saying there weren't enough significant federal issues to justify keeping the cases in federal court.

GSK had argued against remanding the cases, saying that they involve embedded federal questions because the states' obligation to pay for Avandia is rooted in the federal Medicaid statutes, and deciding whether the company misrepresented Avandia requires interpretation of decisions by the...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers

Required